| |
| |
|
| Insider
Information: |
Richardson Hartley T |
| Relationship: |
Director |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,960,700 |
|
|
Indirect Shares
|
7,177,835 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$6 |
|
|
| Total
Shares |
9,138,535 |
|
|
| Total
Value |
$7 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
Former Director/Consul... |
2009-07-02 |
1,761,000 |
2008-03-31 |
751,000 |
Premium* |
|
|
Epirus Biopharmaceuticals Inc |
EPRS |
Director |
2010-04-22 |
199,700 |
2010-04-22 |
6,426,835 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2010-04-22 |
4 |
B |
$1.36 |
$466 |
D/D |
343 |
199,700 |
2.31 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2010-04-13 |
4 |
B |
$1.24 |
$199,888 |
D/D |
161,200 |
199,357 |
2.39 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2010-01-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,137,569) |
6,426,834 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2010-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,111) |
38,157 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2009-12-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,564,403 |
|
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2009-12-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,268 |
|
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Former Director/Consultant |
– – – |
2009-07-02 |
4/A |
OE |
$0.21 |
$2,100 |
D/D |
10,000 |
1,761,000 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Director |
– • – |
2008-11-27 |
4 |
B |
$0.16 |
$34,175 |
D/D |
209,500 |
1,751,000 |
2.39 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Director |
– • – |
2008-11-26 |
4 |
B |
$0.15 |
$9,980 |
D/D |
65,500 |
1,541,500 |
2.39 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Director |
– • – |
2008-11-25 |
4 |
B |
$0.14 |
$42,000 |
D/D |
300,000 |
1,476,000 |
2.39 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Director |
– • – |
2008-03-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
751,000 |
|
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
Director |
– • – |
2008-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
425,000 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
